CASADEI, CHIARA
CASADEI, CHIARA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Dottorandi
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants
2025 Palleschi, M.; Virga, A.; Scarpi, E.; Fonzi, E.; Musolino, A.; Merloni, F.; Sarti, S.; Danesi, R.; Ravegnani, M.; Casadei, C.; Sirico, M.; Gianni, C.; Maltoni, R.; Bravaccini, S.; Calistri, D.; Arcangeli, V.; Zampiga, V.; Cangini, I.; Bandini, E.; Mannozzi, F.; Falcini, F.; Martinelli, G.; De Giorgi, U.; Ulivi, P.; Tedaldi, G.
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors
2025 Farolfi, A.; Montanari, D.; Casadei, C.; Musolino, A.
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
2024 Casadei C.; Scarpi E.; Conteduca V.; Gurioli G.; Cursano M.C.; Brighi N.; Lolli C.; Schepisi G.; Basso U.; Fornarini G.; Bleve S.; Farolfi A.; Altavilla A.; Burgio S.L.; Giunta E.F.; Gianni C.; Filograna A.; Ulivi P.; Olmos D.; Castro E.; De Giorgi U.
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
2023 Cursano, Maria Concetta; Giunta, Emilio Francesco; Scarpi, Emanuela; Casadei, Chiara; Virga, Alessandra; Ulivi, Paola; Bleve, Sara; Brighi, Nicole; Ravaglia, Giorgia; Pantano, Francesco; Conteduca, Vincenza; Santini, Daniele; De Giorgi, Ugo
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
2023 Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U.
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure
2023 Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei, Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
2023 Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecconetto L.; Mariotti M.; De Giorgi U.
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
2023 Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; De Giorgi U.
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
2022 Conteduca V.; Casadei C.; Scarpi E.; Brighi N.; Schepisi G.; Lolli C.; Gurioli G.; Toma I.; Poti G.; Farolfi A.; De Giorgi U.
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
2022 Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecconetto L.; Di Menna G.; Schettini F.; De Giorgi U.
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer
2022 Cursano, M. C.; Conteduca, V.; Scarpi, E.; Gurioli, G.; Casadei, C.; Gargiulo, S.; Altavilla, A.; Lolli, C.; Vincenzi, B.; Tonini, G.; Santini, D.; De Giorgi, U.
Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough?
2021 Palleschi M.; Scarpi E.; Casadei C.
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor
2021 Palleschi M.; Iaia M.L.; Casadei C.
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress
2021 De Padova S.; Urbini M.; Schepisi G.; Virga A.; Meggiolaro E.; Rossi L.; Fabbri F.; Bertelli T.; Ulivi P.; Ruffilli F.; Casadei C.; Gurioli G.; Rosti G.; Grassi L.; De Giorgi U.
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma
2020 Lolli C.; Altavilla A.; Conteduca V.; Farolfi A.; Casadei C.; Schepisi G.; Banna G.L.; De Giorgi U.
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
2020 Altavilla A.; Casadei C.; Lolli C.; Menna C.; Ravaglia G.; Gurioli G.; Farolfi A.; Brighi N.; Conteduca V.; Burgio S.L.; Schepisi G.; Rossi L.; Gargiulo S.; Lisotti I.; De Giorgi U.
Immune modulation in prostate cancer patients treated with androgen receptor (Ar)-targeted therapy
2020 Conteduca V.; Caffo O.; Scarpi E.; Sepe P.; Galli L.; Fratino L.; Maines F.; Chiuri V.E.; Santoni M.; Zanardi E.; Massari F.; Toma I.; Lolli C.; Schepisi G.; Sbrana A.; Kinspergher S.; Cursano M.C.; Casadei C.; Modonesi C.; Santini D.; Procopio G.; De Giorgi U.
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immuno-oncology: A real-world study on behalf of Meet-URO group (MeetUro-7b)
2020 Stellato, M; Santini, D; Verzoni, E; De Giorgi, U; Casadei, C; Buti, S; Maruzzo, M; Murianni, V; Sbrana, A; Di Lorenzo, G; Anesi, C; Sorarù, M; Naglieri, E; De Vivo, R; Vignani, F; Grillone, F; Mucciarini, C; Roviello, G; Pignata, S; Procopio, G
Aeromonas veronii biovar veronii and sepsis-infrequent complication of biliary drainage placement: A case report
2019 Monti, M.; Torri, A.; Amadori, E.; Rossi, A.; Bartolini, G.; Casadei, C.; Frassineti, G. L.
Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC)
2019 Conteduca, V; Wetterskog, D; Scarpi, E; Romanel, A; Gurioli, G; Jayaram, A; Lolli, C; Schepisi, G; Casadei, C; Menna, C; Wingate, A; Demichelis, F; De Giorgi, U; Attard, G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants | Palleschi, M.; Virga, A.; Scarpi, E.; Fonzi, E.; Musolino, A.; Merloni, F.; Sarti, S.; Danesi, R....; Ravegnani, M.; Casadei, C.; Sirico, M.; Gianni, C.; Maltoni, R.; Bravaccini, S.; Calistri, D.; Arcangeli, V.; Zampiga, V.; Cangini, I.; Bandini, E.; Mannozzi, F.; Falcini, F.; Martinelli, G.; De Giorgi, U.; Ulivi, P.; Tedaldi, G. | 2025-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | The Oncologist.pdf; file supplementari.zip |
| Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors | Farolfi, A.; Montanari, D.; Casadei, C.; Musolino, A. | 2025-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-13-00528.pdf |
| Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study | Casadei C.; Scarpi E.; Conteduca V.; Gurioli G.; Cursano M.C.; Brighi N.; Lolli C.; Schepisi G.; ...Basso U.; Fornarini G.; Bleve S.; Farolfi A.; Altavilla A.; Burgio S.L.; Giunta E.F.; Gianni C.; Filograna A.; Ulivi P.; Olmos D.; Castro E.; De Giorgi U. | 2024-01-01 | EUROPEAN UROLOGY OPEN SCIENCE | - | 1.01 Articolo in rivista | Inherited Mutations in DNA Damage Repair Genes from Meet-URO 10 Study.pdf |
| Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer | Cursano, Maria Concetta; Giunta, Emilio Francesco; Scarpi, Emanuela; Casadei, Chiara; Virga, Ales...sandra; Ulivi, Paola; Bleve, Sara; Brighi, Nicole; Ravaglia, Giorgia; Pantano, Francesco; Conteduca, Vincenza; Santini, Daniele; De Giorgi, Ugo | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Cursano et al, Impact of somatic_ 2023_august.pdf |
| Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology | Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico ...M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Merloni_2023.pdf |
| Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure | Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei..., Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo | 2023-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 2023-Merloni (Ther Adv Med Oncol)- Oligometastatic breast cancer REVIEW.pdf |
| Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer | Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecc...onetto L.; Mariotti M.; De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Potential Impact of Preoperative Circulating Biomarkers.pdf |
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer | Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; ...De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide | Conteduca V.; Casadei C.; Scarpi E.; Brighi N.; Schepisi G.; Lolli C.; Gurioli G.; Toma I.; Poti ...G.; Farolfi A.; De Giorgi U. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | aseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer.pdf |
| Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment | Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecc...onetto L.; Di Menna G.; Schettini F.; De Giorgi U. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Circulating inflammatory cells in patients with metastatic breast cancer Implications for treatment.pdf |
| Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer | Cursano, M. C.; Conteduca, V.; Scarpi, E.; Gurioli, G.; Casadei, C.; Gargiulo, S.; Altavilla, A.;... Lolli, C.; Vincenzi, B.; Tonini, G.; Santini, D.; De Giorgi, U. | 2022-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | Grade group system.pdf |
| Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough? | Palleschi M.; Scarpi E.; Casadei C. | 2021-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Germline BRCA-mutated metastatic breast cancer with positive hormone receptor | Palleschi M.; Iaia M.L.; Casadei C. | 2021-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.04 Replica / breve intervento (e simili) | - |
| Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress | De Padova S.; Urbini M.; Schepisi G.; Virga A.; Meggiolaro E.; Rossi L.; Fabbri F.; Bertelli T.; ...Ulivi P.; Ruffilli F.; Casadei C.; Gurioli G.; Rosti G.; Grassi L.; De Giorgi U. | 2021-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-10-564346.pdf |
| A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma | Lolli C.; Altavilla A.; Conteduca V.; Farolfi A.; Casadei C.; Schepisi G.; Banna G.L.; De Giorgi U. | 2020-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer | Altavilla A.; Casadei C.; Lolli C.; Menna C.; Ravaglia G.; Gurioli G.; Farolfi A.; Brighi N.; Con...teduca V.; Burgio S.L.; Schepisi G.; Rossi L.; Gargiulo S.; Lisotti I.; De Giorgi U. | 2020-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| Immune modulation in prostate cancer patients treated with androgen receptor (Ar)-targeted therapy | Conteduca V.; Caffo O.; Scarpi E.; Sepe P.; Galli L.; Fratino L.; Maines F.; Chiuri V.E.; Santoni... M.; Zanardi E.; Massari F.; Toma I.; Lolli C.; Schepisi G.; Sbrana A.; Kinspergher S.; Cursano M.C.; Casadei C.; Modonesi C.; Santini D.; Procopio G.; De Giorgi U. | 2020-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | Journal Clinical Medicine [Conteduca].pdf |
| Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immuno-oncology: A real-world study on behalf of Meet-URO group (MeetUro-7b) | Stellato, M; Santini, D; Verzoni, E; De Giorgi, U; Casadei, C; Buti, S; Maruzzo, M; Murianni, V; ...Sbrana, A; Di Lorenzo, G; Anesi, C; Sorarù, M; Naglieri, E; De Vivo, R; Vignani, F; Grillone, F; Mucciarini, C; Roviello, G; Pignata, S; Procopio, G | 2020-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Aeromonas veronii biovar veronii and sepsis-infrequent complication of biliary drainage placement: A case report | Monti, M.; Torri, A.; Amadori, E.; Rossi, A.; Bartolini, G.; Casadei, C.; Frassineti, G. L. | 2019-01-01 | WORLD JOURNAL OF CLINICAL CASES | - | 1.01 Articolo in rivista | - |
| Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC) | Conteduca, V; Wetterskog, D; Scarpi, E; Romanel, A; Gurioli, G; Jayaram, A; Lolli, C; Schepisi, G...; Casadei, C; Menna, C; Wingate, A; Demichelis, F; De Giorgi, U; Attard, G | 2019-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |